These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16523535)

  • 21. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
    Goode KM; Clark AL; Cleland JG
    Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation].
    Jernberg T; Boman K; James S; Lindahl B; Stridsberg M; Swedberg K; Venge P
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1289-92, 1295. PubMed ID: 16708856
    [No Abstract]   [Full Text] [Related]  

  • 24. B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary disease.
    Maisel AS; DiSomma S
    Crit Care Med; 2007 Jan; 35(1):301-3. PubMed ID: 17197774
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptide as a marker of heart failure: Not so specific after all?
    Marshall W; Orlando R
    Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB; Barrett-Connor E
    J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract]   [Full Text] [Related]  

  • 30. Whose heart will get broken? Troponin testing and future heart failure.
    van Kimmenade RR; Januzzi JL
    Eur Heart J; 2009 Apr; 30(7):755-6. PubMed ID: 19264751
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cut-off values of BNP and NT-BNP for diagnosis of heart failure in emergency service].
    Akpinar O; Kanadaşi M; Ilgenli TF
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):395-6. PubMed ID: 17162299
    [No Abstract]   [Full Text] [Related]  

  • 32. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proBNP: improved standard in CHF diagnosis.
    Bluestein B; Belenky A
    MLO Med Lab Obs; 2008 Dec; 40(12):20, 22, 24. PubMed ID: 19160707
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to "Getting the right message".
    Januzzi JL; Camargo CA; Tung R
    Ann Emerg Med; 2007 Mar; 49(3):381-3; discussion 383; author reply 384. PubMed ID: 17317512
    [No Abstract]   [Full Text] [Related]  

  • 35. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Apple FS; Ravkilde J; Wu AH;
    Circulation; 2007 Jul; 116(5):e99-109. PubMed ID: 17630410
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure.
    Huang DJ
    Chin Med J (Engl); 2009 Mar; 122(6):608-9. PubMed ID: 19323919
    [No Abstract]   [Full Text] [Related]  

  • 37. Getting the right message: avoiding overly optimistic interpretations of the scientific literature.
    Schriger DL
    Ann Emerg Med; 2006 Jul; 48(1):75-6. PubMed ID: 16781922
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum biomarkers for heart failure.
    Jarolim P
    Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.